FDA Approves First Capsule for Postpartum Despair
[ad_1] Aug. 7, 2023 – The FDA has authorized the primary oral drug for postpartum melancholy, a situation that impacts an estimated one in seven moms in america. The tablet, zuranolone (model title Zurzuvae), is a steroid that acts on sure receptors within the mind that regulate temper, arousal, habits, and cognition, in keeping with